#gmp compliance

Discover 2 curated intelligence briefings related to this specific topic.

The Vein-to-Vein Race: Why the Hospital is the New Bio-Factory
Health & Medicine

The Vein-to-Vein Race: Why the Hospital is the New Bio-Factory

The traditional centralized model of cell therapy is breaking. We are witnessing a pivot toward on-site biomanufacturing that slashes delivery times from weeks to days, fundamentally altering the prognosis for late-stage cancer patients globally.

Read Analysis
Southeast Asia Is Seizing the Molecular Supply Chain
Technology & Innovation

Southeast Asia Is Seizing the Molecular Supply Chain

While the world watches the chip wars, ASEAN is quietly building a high-precision infrastructure for cell therapies, battery chemistry, and agricultural biotechnology, shifting the region from a low-cost hub to a molecular powerhouse.

Read Analysis